Physician profile
William Boyan
NPI 1376980896
$1,110.92
in general payments reported to CMS, 2019-2025
10 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.65 · 2022: $185 · 2024: $442 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $489.13 | 2024-2025 | Hemoblast Bellows |
| Kerecis Limited | $169.64 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Davol INC. | $146.77 | 2022 | |
| Intuitive Surgical, INC. | $71.97 | 2021-2024 | |
| Lexington Medical, INC. | $63.24 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Smith+Nephew, INC. | $55.13 | 2022-2024 | Pico 14 |
| Advanced Oxygen Therapy INC. | $36.95 | 2025 | Topical Oxygen Chamber For Extremities |
| Tela Bio, INC. | $34.91 | 2024 | Ovitex 2s |
| Medtronic, INC. | $26.18 | 2025 | Maxtack |
| W. L. Gore & Associates, INC. | $17.00 | 2024 | Gore Synecor Biomaterial |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Boyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.